Corcept shareholders elect nine directors, ratify Ernst & Young, approve executive comp at annual meeting

CORCEPT THERAPEUTICS INC

All nine director nominees elected with substantial support; David Mahoney received 62.7M for, 14.7M withheld.
Ernst & Young ratified as auditor for FY 2025 with 90.5M votes for, 1.5M against.
Advisory vote on executive compensation approved with 72.9M for, 4.2M against, 14.9M broker non-votes.
Total shares voted: 92.3M out of 106.0M eligible shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.